Search
for

    Sort by

    Research 211–240 of 334

    1. B‐ RAF , naevi and melanoma: a complex relationship British Journal of Dermatology · 2014
    2. BAYONET trial: staged combination with encorafenib, binimetinib, plus cetuximab following encorafenib plus cetuximab for BRAF V600E-mutant metastatic colorectal cancer ESMO Gastrointestinal Oncology · 2024
    3. Hair and nail adverse events during treatment with targeted therapies for metastatic melanoma 2016 · 32 citations
    4. Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs 2012 · 29 citations
    5. Cutaneous toxicities of new treatments for melanoma Clinical & Translational Oncology · 2018 · 25 citations
    6. The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B‐rapidly accelerated fibrosarcoma‐mutated advanced melanoma Journal of the European Academy of Dermatology and Venereology · 2018 · 21 citations
    7. Management of Dermatologic Toxicities Journal of the National Comprehensive Cancer Network · 2015 · 12 citations
    8. Hair(y) Matters in Melanoma Biology Trends in molecular medicine · 2020 · 7 citations
    9. Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy Dermatology Review · 2016 · 4 citations
    10. Diagnosis and Management of Melanoma of the Scalp: A Review of the Literature Clinical, Cosmetic and Investigational Dermatology · 2021 · 3 citations
    11. At the Root: Cutaneous Langerhans Cell Histiocytosis The American Journal of Medicine · 2018 · 3 citations
    12. The Influence of Flightless I: Regeneration versus Wound Healing Journal of Investigative Dermatology · 2011 · 1 citations
    13. Alopecia due to chemotherapeutics, hedgehog inhibitors, targeted antibody therapies and immune checkpoint inhibitors Deleted Journal · 2024
    14. Dyad of infantile cutaneous and thymic Langerhans cell histiocytosis: Is it rare? Pediatric blood & cancer · 2023
    15. Author response: Dynamics of nevus development implicate cell cooperation in the growth arrest of transformed melanocytes 2020
    16. Decision letter: Dynamics of nevus development implicate cell cooperation in the growth arrest of transformed melanocytes 2020
    17. Inflammatory and non-melanocytic tumoral pathology of the nail Pathology · 2014
    18. Tombo em João Pessoa dá força a Memorial da Arquitetura Paraibana Projeto: revista mensal de arquitetura · 2008
    19. Is knowledge about the genetic and epigenetic alterations in melanoma a basis for targeted therapy? Experimental Dermatology · 2006
    20. A cross-sectional study of clinical, dermoscopic, histopathological, and molecular patterns of scalp melanoma in patients with or without androgenetic alopecia Scientific Reports · 2022
    21. A cross-sectional study of clinical, dermoscopic, histopathological, and molecular patterns of scalp melanoma in patients with or without androgenetic alopecia 2022
    22. Exploiting the origins of Ras mediated squamous cell carcinoma to develop novel therapeutic interventions Small GTPases · 2011 · 3 citations
    23. Targeted therapy in melanoma Clinics in Dermatology · 2013 · 21 citations
    24. Genetics of thyroid lesions updated Pathology · 2014
    25. Progress in Dermatology and Venereology in 2023 as reflected in the Journal of the European Academy of Dermatology and Venereology 2023
    26. Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma Archives of Medical Science · 2017 · 16 citations
    27. America - A Diversity of Life Styles. NJEA Review · 1975
    28. Kinase Inhibition with BAY 43–9006 in Renal Cell Carcinoma Clinical cancer research · 2004 · 234 citations
    29. Can you diagnose hair loss (Non-scarring alopecia) Pathology · 2014
    30. 559 Visualization of sweat suppression following botulinum toxin A by soluble microneedle arrays Journal of Investigative Dermatology · 2016